Follow
Michael Binks
Michael Binks
Rare Disease Research Unit, Pfizer Inc
Verified email at pfizer.com
Title
Cited by
Cited by
Year
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
M Binks, JR Passweg, D Furst, P McSweeney, K Sullivan, C Besenthal, ...
Annals of the rheumatic diseases 60 (6), 577-584, 2001
3472001
Intrinsic dendritic cell abnormalities in Wiskott‐Aldrich syndrome
M Binks, GE Jones, PM Brickell, C Kinnon, DR Katz, AJ Thrasher
European journal of immunology 28 (10), 3259-3267, 1998
1571998
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
D Mewar, A Coote, DJ Moore, I Marinou, J Keyworth, MC Dickson, ...
Arthritis research & therapy 8, 1-5, 2006
1522006
Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor α, tumor necrosis factor receptor superfamily member …
I Rioja, FJ Hughes, CH Sharp, LC Warnock, DS Montgomery, M Akil, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2008
1462008
In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen
H Drakesmith, D O’Neil, SC Schneider, M Binks, P Medd, E Sercarz, ...
Proceedings of the National Academy of Sciences 95 (25), 14903-14908, 1998
1231998
Association of interleukin‐6 and interleukin‐10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status
I Marinou, J Healy, D Mewar, DJ Moore, MC Dickson, MH Binks, ...
Arthritis & Rheumatism 56 (8), 2549-2556, 2007
1052007
Genetic association of the major histocompatibility complex with rheumatoid arthritis implicates two non‐DRB1 loci
C Vignal, AT Bansal, DJ Balding, MH Binks, MC Dickson, DS Montgomery, ...
Arthritis & Rheumatism 60 (1), 53-62, 2009
922009
Innovative randomized phase I study and dosing regimen selection to accelerate and inform pivotal COVID‐19 trial of nirmatrelvir
RSP Singh, SS Toussi, F Hackman, PL Chan, R Rao, R Allen, L Van Eyck, ...
Clinical Pharmacology & Therapeutics 112 (1), 101-111, 2022
862022
Human macrophage migration inhibitory factor: a proven immunomodulatory cytokine?
A Kudrin, M Scott, S Martin, C Chung, R Donn, A McMaster, S Ellison, ...
Journal of biological chemistry 281 (40), 29641-29651, 2006
822006
Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo‐controlled phase IIa study
VJ Ludbrook, KJ Hicks, KE Hanrott, JS Patel, MH Binks, MR Wyres, ...
British Journal of Dermatology 174 (5), 985-995, 2016
772016
Novel molecular mechanisms of dendritic cell-induced T cell activation
VE Woodhead, TJ Stonehouse, MH Binks, K Speidel, DA Fox, A Gaya, ...
International Immunology 12 (7), 1051-1061, 2000
662000
Pure populations of transduced primary human cells can be produced using GFP expressing herpes virus vectors and flow cytometry
RS Coffin, SK Thomas, NSB Thomas, CE Lilley, AR Pizzey, CH Griffiths, ...
Gene therapy 5 (5), 718-722, 1998
631998
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy
E Mercuri, JE Signorovitch, E Swallow, J Song, SJ Ward, M Pane, ...
Neuromuscular Disorders 26 (9), 576-583, 2016
622016
From sentinel to messenger: an extended phenotypic analysis of the monocyte to dendritic cell transition
WOODHEAD, BINKS, CHAIN, KATZ
Immunology 94 (4), 552-559, 1998
611998
Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus
L Kahl, J Patel, M Layton, M Binks, K Hicks, G Leon, E Hachulla, ...
Lupus 25 (13), 1420-1430, 2016
602016
Association between radiographic severity of rheumatoid arthritis and shared epitope alleles: differing mechanisms of susceptibility and protection
D Mewar, I Marinou, AL Coote, DJ Moore, M Akil, D Smillie, MC Dickson, ...
Annals of the rheumatic diseases 67 (7), 980-983, 2008
562008
Safety, tolerability, pharmacokinetics, and pharmacodynamics of domagrozumab (PF‐06252616), an antimyostatin monoclonal antibody, in healthy subjects
I Bhattacharya, S Pawlak, S Marraffino, J Christensen, SP Sherlock, ...
Clinical Pharmacology in Drug Development 7 (5), 484-497, 2018
512018
Quantitative power Doppler ultrasonography is a sensitive measure of metacarpophalangeal joint synovial vascularity in rheumatoid arthritis and declines significantly following …
MJ Larché, M Seymour, A Lim, RJ Eckersley, F Pétavy, F Chiesa, I Rioja, ...
The Journal of rheumatology 37 (12), 2493-2501, 2010
472010
Radiographic hand joint space width assessed by computer is a sensitive measure of change in early rheumatoid arthritis.
J Angwin, A Lloyd, G Heald, G Nepom, M Binks, MF James
The Journal of rheumatology 31 (6), 1050-1061, 2004
472004
Report of a TREAT-NMD/world duchenne organisation meeting on dystrophin quantification methodology
A Aartsma-Rus, J Morgan, P Lonkar, H Neubert, J Owens, M Binks, ...
Journal of neuromuscular diseases 6 (1), 147-159, 2019
452019
The system can't perform the operation now. Try again later.
Articles 1–20